腺体原位先天性甲状腺功能减退症的严重程度可预测靶向二代测序的分子检出率
研究对法国国家筛查项目转诊至昂热大学医院罕见甲状腺疾病参考中心的103例腺体原位先天性甲状腺功能减退症(CH-GIS)患者进行48基因靶向二代测序,25例确诊、18例可能确诊,分子检出率42%;TSHsc≥80 mUI/L或FT4dg≤5 pmol/L时检出率增至70%。
要点
- 103例CH-GIS患者中靶向NGS检出25例确诊和18例可能确诊,总分子检出率42%。
- TSHsc≥80 mUI/L时分子检出率73%,<80 mUI/L时为25%。
- TSHdg≥100 mUI/L时分子检出率60%,<100 mUI/L时为30%;FT4dg≤5 pmol/L时69%,>5 pmol/L时为29%。
核心结论
- 法国CH-GIS患者靶向NGS的分子检出率为42%,当TSHsc≥80 mUI/L或FT4dg≤5 pmol/L时增至70%。
研究设计与样本
- 对来自法国国家筛查项目、转诊至昂热大学医院罕见甲状腺疾病参考中心的103例CH-GIS患者进行靶向二代测序,使用包含48个基因的定制面板。
- 根据基因已知遗传方式、美国医学遗传学与基因组学学会变异分类、家系分离及已发表功能研究,将病例分为确诊或可能确诊。
主要发现
- 在103例患者中的73例检出10个基因的95个变异,其中25例为确诊、18例为可能确诊。
- 变异主要位于TG基因(n=20)和TPO基因(n=15)。
- TSHsc≥80 mUI/L时分子检出率为73%,<80 mUI/L时为25%。
- TSHdg≥100 mUI/L时分子检出率为60%,<100 mUI/L时为30%;FT4dg≤5 pmol/L时为69%,>5 pmol/L时为29%。
关键数值与推荐
- TSHsc≥80 mUI/L者分子检出率73%,TSHsc<80 mUI/L者25%。
- TSHdg≥100 mUI/L者分子检出率60%,TSHdg<100 mUI/L者30%。
- FT4dg≤5 pmol/L者分子检出率69%,FT4dg>5 pmol/L者29%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Congenital hypothyroidism with gland-in-situ (CH-GIS) is usually attributed to mutations in the genes involved in thyroid hormone production. The diagnostic yield of targeted next-generation sequencing (NGS) varied widely between studies. We hypothesized that the molecular yield of targeted NGS would depend on the severity of CH. METHODS: Targeted NGS was performed in 103 CH-GIS patients from the French national screening program referred to the Reference Center for Rare Thyroid Diseases of Angers University Hospital. The custom targeted NGS panel contained 48 genes. Cases were classified as solved or probably solved depending on the known inheritance of the gene, the classification of the variants according to the American College of Medical Genetics and Genomics, the familial segregation, and published functional studies. Thyroid-stimulating hormone at CH screening and at diagnosis (TSHsc and TSHdg) and free T4 at diagnosis (FT4dg) were recorded. RESULTS: NGS identified 95 variants in 10 genes in 73 of the 103 patients, resulting in 25 solved cases and 18 probably solved cases. They were mainly due to mutations in the TG (n = 20) and TPO (n = 15) genes. The molecular yield was, respectively, 73% and 25% if TSHsc was ≥ and < 80 mUI/L, 60% and 30% if TSHdg was ≥ and < 100 mUI/L, and 69% and 29% if FT4dg was ≤ and > 5 pmol/L. CONCLUSION: NGS in patients with CH-GIS in France found a molecular explanation in 42% of the cases, increasing to 70% when TSHsc was ≥ 80 mUI/L or FT4dg was ≤ 5 pmol/L.
引用
- Levaillant L, Bouhours-Nouet N, Illouz F, et al. The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation Sequencing. J Clin Endocrinol Metab. 2023. PMID: 36884306. doi:10.1210/clinem/dgad119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。